Professor Chaoxu Zheng: Non-Invasive, Painless Surgery That Preserves Dignity—The Ultimate Goal in Colorectal Cancer Surgery   | Annual Meeting of the Chinese Medical Doctor Association Colorectal Oncology Committee

Professor Chaoxu Zheng: Non-Invasive, Painless Surgery That Preserves Dignity—The Ultimate Goal in Colorectal Cancer Surgery   | Annual Meeting of the Chinese Medical Doctor Association Colorectal Oncology Committee

From February 28 to March 1, 2025, the 9th Annual Meeting of the Chinese Medical Doctor Association Colorectal Oncology Committee was held in Beijing. This year’s meeting focused on the standardization, precision, and personalization of colorectal cancer diagnosis and treatment, drawing top experts from China and around the world to explore the latest advances in the field.
Mok Talk | Master Tony Mok on Research, Leadership, and the Future of Lung Cancer in China

Mok Talk | Master Tony Mok on Research, Leadership, and the Future of Lung Cancer in China

As lung cancer diagnosis and treatment enter an era of precision and personalization, Chinese researchers are playing an increasingly pivotal role on the international stage through innovation and collaboration. In this special edition of the Mok Talk interview series, hosted by the talented Professor Yang Xia of The Second Affiliated Hospital of Zhejiang University School of Medicine, we are honored to present a conversation with world-renowned lung cancer expert Professor Tony Mok from The Chinese University of Hong Kong. Joining him are prominent early-career scholars such as Professor Wenhua Liang (The First Affiliated Hospital of Guangzhou Medical University) and Professor Yongchang Zhang (Hunan Cancer Hospital). Together, they discuss academic growth, clinical trial design, and the global impact of Chinese innovations—offering a meaningful intergenerational exchange of ideas.
EAU 2025 | Professors Haige Chen and Ruiyun Zhang Share Advances in Non-Invasive Bladder-Sparing Detection and Targeted-Immunotherapy Combinations

EAU 2025 | Professors Haige Chen and Ruiyun Zhang Share Advances in Non-Invasive Bladder-Sparing Detection and Targeted-Immunotherapy Combinations

Trimodality therapy (TMT)is a well-established bladder-sparing strategy for patients with muscle-invasive bladder cancer (MIBC). However, limitations remain for patients intolerant to chemotherapy and in monitoring post-treatment recurrence. Professors Haige Chen and Ruiyun Zhang of Renji Hospital, Shanghai Jiao Tong University School of Medicine, have long focused on MIBC research. This year, nine of their studies were accepted at the EAU Congress. UroStream invited Professors Chen and Zhang to share their insights on emerging approaches, including chemotherapy-free strategies combining the domestic ADC drug RC48 with PD-1 inhibitors, the value of utDNA in non-invasive monitoring, AI-based molecular subtyping, and major takeaways from the congress.
SGBCC 2025 | Prof. Zefei Jiang has an in-depth dialogue with Prof. Michael Gnant: Combining Chinese and Western Approaches and Listening to the Voice of China at SGBCC

SGBCC 2025 | Prof. Zefei Jiang has an in-depth dialogue with Prof. Michael Gnant: Combining Chinese and Western Approaches and Listening to the Voice of China at SGBCC

From March 12 to 15, 2025, the 19th St. Gallen Breast Cancer Conference (SGBCC) was held with great success. During the conference, the Chinese Society of Clinical Oncology (CSCO) and SGBCC jointly organized the "Voice of China" session, showcasing China's advancements in clinical research, basic science, translational medicine, and radiomics within the breast cancer field, which sparked vibrant discussions among global experts. “Oncology Frontier” invited the co-chairs of this session—Prof. Zefei Jiang (St.Gallen International Consensus panel Member, CSCO President-Elect, Chinese PLA General Hospital) and Prof. Michael Gnant (SGBCC Conference Chair, Comprehensive Cancer Center, Medical University of Vienna)—to engage in a profound dialogue on the future of Sino-global collaboration.